Ranking of Antimicrobial Drugs According to Importance in Human Medicine John H. Powers, M.D. Lead Medical Officer Antimicrobial Drug Development and Resistance.

Slides:



Advertisements
Similar presentations
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Advertisements

TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
Mechanisms of Genetic Variation 1 16 Copyright © McGraw-Hill Global Education Holdings, LLC. Permission required for reproduction or display.
Younas Masih RN, Post RN BSc.N (Lecturer ) New Life College Of Nursing Karachi 11/7/20141Antimicrobial medications.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
BETHLEHEM UNIVERSITY Second Neonatal Gathering Fall 2007.
Role of MRSA Swabs for De-escalation of Antibiotics in HCAP
Clinical Trials Medical Interventions
PHL 424 Antimicrobials 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
PHL 521 Clinical Dental Therapeutics 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Office of Drug Evaluation IV, CDER FDA/IDSA/ISAP Workshop 4/16/04 Overview of PK-PD in Drug Development Programs: FDA Perspective FDA/IDSA/ISAP Workshop.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
Non-pharmacologic Elevate the affected area to facilitate gravity drainage of edema and inflammatory substances – Patients with edema may benefit from.
MDR Organisms in Holy Family Hospital Rawalpindi
IDSA / ISAP / FDA Workshop on Antimicrobial Drug Development Update 2004 Edward Cox, MD MPH ODE IV Center for Drug Evaluation and Research US Food and.
A new antivirulence approach against pathogenic bacteria A new antivirulence approach against pathogenic bacteria May 2005 Sonia Escaich - President &
Today, infectious diseases have the potential to spread quickly throughout the world.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
The Antibiotic Sensitivity Test Presented by Marian Mikhail Undergraduate student Biology Major Health and Science Concentration Health and Science Concentration.
Emerging Viruses BY PLAN A. Topic Questions  Why are these new viruses more harmful compared to the previous form of the virus?  Why is it so difficult.
Relating Food Animal and Human Antimicrobial Use Comments to the FDA Anti-Infective Drugs Advisory Committee on behalf of the on behalf of the American.
PK/PD of Antibiotics in relation to resistance Otto Cars MD Department of Medical Sciences Infectious diseases Uppsala University Sweden.
Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.
Antibiotics!.
Can the Application of the International Health Regulations to Antimicrobial Resistance Events Help to Preserve Antimicrobials? AMR 1, abstract N° 406.
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Non-O157 STEC: New Challenges / Practical Limitations / Next Steps Robert L. Buchanan HHS Food and Drug Administration Center for Food Safety and Applied.
General Principles of Antimicrobial Therapy. Concept #1: The guiding principle of antibiotic selection Antibiotic coverage should be kept to the narrowest.
Toward More Rational Risk Analysis: Improving the ranking process in #152 Tony Cox Cox Associates FDA Anti-Infective Drugs Advisory Committeee Meeting.
Antibiotics Broad Spectrum vs Narrow Spectrum. Two Groups of antibiotics An antibiotic may be classified basically as "narrow- spectrum" or "broad-spectrum"
Natural Selection. evolution – The development of new species as a result of natural selection. extinction – The complete disappearance of a species due.
Antimicrobial Resistance in Streptococcus pneumoniae Implications for Prescription Drug Labeling John H. Powers, MD Lead Medical Officer Antimicrobial.
DENS 521 Clinical Dental Therapeutics 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Starter Outline how variation, adaptation and selection are major components of evolution [4] Variation must exist before evolution can occur Environment.
Ranking of Antimicrobial Drugs Relative to Their Use in Animals Richard Carnevale VMD Vice President, Scientific, Regulatory and International Affairs.
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Lesson Overview Lesson Overview Diseases Caused by Bacteria and Viruses Lesson Overview 20.3 Diseases Caused by Bacteria and Viruses.
The Efficacy of Topical Manuka Honey and Combination Antibiotic Therapy in the Treatment of MRSA Skin Infections Kyle Liban Pacific University School of.
An agency of the European Union Principles for the assessment and authorisation of antimicrobials in the EU VICH Outreach Forum, October 2015 Presented.
Tigecycline use in serious nosocomial infections: a drug use evaluation Matteo Bassetti*, Laura Nicolini, Ernestina Repetto, Elda Righi, Valerio Del Bono,
Peter Jones Antimicrobials -Are we using them responsibly? Peter Jones Workshop on Strengthening Livestock Health and Veterinary Services in Ukraine KIEV,
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
IMPORTANT ANTIBIOTICS AND ANTIMICROBIAL RESISTANCE A Presentation By Ms R.Venkatajothi, MSc., MPhil, PhD Senior Lecturer Department of Microbiology Faculty.
Assessing Antimicrobial Resistance Risks: VICH GL 27 & FDA Guidance for Industry #152 Comments by Heather Harbottle, Ph.D. Microbial Food Safety Team (HFV-157)
Antimicrobial Stewardship
Section 3: Bacteria, Viruses, and Humans
Antibiotic Resistance
Clinical Trials Medical Interventions
Antibiotic Resistance
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
Medical Microbiology Chapter 24 Enterococcus.
A new antivirulence approach against pathogenic bacteria
Clinical Trials.
Infectious Disease.
Chemotherapeutic agent
Drug Resistance Bacteria are considered resistant to an antibiotic if the maximal level of that antibiotic that can be tolerated by the host does not halt.
Fluoroquinolone Nalidixic acid is the predecessor to all fluoroquinolones, a class of man-made antibiotics. Fluoroquinolones in use today typically offer.
Antimicrobial resistance
Presentation transcript:

Ranking of Antimicrobial Drugs According to Importance in Human Medicine John H. Powers, M.D. Lead Medical Officer Antimicrobial Drug Development and Resistance Initiatives Office of Drug Evaluation IV Center for Drug Evaluation and Research U.S. Food and Drug Administration

2 Introduction u Define problem of antimicrobial use in animals and relationship to antimicrobial resistance in human pathogens u Background on ranking process u Factors used in ranking drugs –factors based on drug efficacy –factors based on resistance –factors of low importance

3 The Problem u Antimicrobial drug use in food-producing animals: –may result is bacteria in animals resistant to drugs used to treat human illness –resistant bacteria in food-producing animals may be transmitted to humans –non-pathogenic bacteria originating in food- producing animals may transmit resistance traits to human pathogenic bacteria

4 The Problem u Antimicrobial use in humans may contribute to most of resistance in man u Antimicrobial use in animals may also contribute u Several authors debate how large a problem this is –How large does it have to be to pose significant risk to human health? –Because is it difficult to measure does it mean it does not exist? u Avoparcin and vancomycin resistance example

5 Examples u Transmission of resistant bacteria from animals to humans –enteric bacteria in animals causing food-borne disease in man most direct link »Salmonella outbreak traced back pigs u Molbak N Engl J Med 1999;341: –Nonenteric bacteria in animals to non-enteric bacteria in man »ROB-1 beta-lactamase in Actinobacillus pleuropneumoniae from pigs transfer via plasmid to H. influenzae in man u Medeiros 1986Antimicrob Agents Chemo 1986;29: –possibility for gene transfer from enteric bacteria in animals to non-enteric bacteria in man »van A gene in enterococci to MRSA?

6 The Problem u Transmission of resistance genes within species or from one species to another –animal specific strains of bacteria can transmit genes to like organisms in humans »transfer between non-isogenic strains of enterococci in Denmark u DANMAP 2000 u Some authors postulate cycle of transmission –man may transmit resistant pathogens to animals via sewage –resistance amplified in animals –transmitted back to man »Teale J Appl Micro 2002;92:85S-89S.

7 Background u Desire to preserve usefulness of antimicrobials of greatest importance in treatment of human disease u Framework document includes categorization of drugs based on relative importance in human medicine –drugs ranked as high, medium or low importance in human medicine based on several factors –considered in hazard identification and consequence assessments »ranking of human drugs not only or overall driver of categorization for drug use in animals u Joint CVM-CDER team developed guidelines for categorization of drugs

8 Background u Ranking includes all drugs, not just those used in treatment of food-borne pathogens u Drugs used in human medicine for food-borne illness also used to treat other non-food-borne diseases u Drugs used to treat non-enteric disease can affect enteric bacteria u Transmission of resistance elements can occur from enteric bacteria to other pathogens which do not cause enteric disease –transmission of resistant determinants from VRE to S. aureus

9 Background u Ranking of drugs not a regular part of CDER review and approval process for antimicrobials. u Approval process entails showing drug product must be safe and effective; demonstrating specific level of importance in human medicine is not required. u Regulatory initiatives do recognize some products may be of greater importance in human medicine. –Subparts E & H: serious and life-threatening disease

10 Background u Qualitative rather than a quantitative system –multiple factors may apply to some drugs u Degree of subjectivity in these determinations –application of general scientific and infectious disease principles u Does not necessarily include all antimicrobial drugs and classes u Ranking expected to evolve over time –new drugs, emergence of diseases, changes in prescribing patterns –review ranking every few years

11 Factors in Ranking u Factors related to drug efficacy 1) sole therapy/limited available therapies 2) therapy of choice 3) spectrum of activity of particular importance 4) importance for oral therapy 5) importance in treating food-borne infections 6) unique mechanism of antimicrobial action u Factors related to development of antimicrobial resistance 7) cross-resistance within drug class 8) cross-resistance across drug classes 9) ease of transmissibility of resistance determinants 10) cross resistance between animal/human drugs

12 Factors in Ranking: Drug Efficacy u Sole or limited available therapy –“high” importance until widespread resistance in humans precludes use or other therapy available »vancomycin or linezolid for MRSA infections u Therapy of choice –not sole therapy but preferred for various reasons »cefazolin for pre-operative prophylaxis –important when treating high mortality/ morbidity infections »ceftriaxone or cefotaxime for acute bacterial meningitis

13 Factors in Ranking: Drug Efficacy u Spectrum of activity of particular importance –drugs used in treatment of infections due to resistant pathogens »dalfopristin/quinupristin for vancomycin resistant enterococcal infections u Importance in oral therapy –use of drug in cases where patient would have required parenteral therapy »fluoroquinolones or trimethoprim-sulfamethoxazole for variety of Gram negative infections

14 Factors in Ranking: Drug Efficacy u Importance in treating food-borne infections –most direct link between infection or colonization in animals and infections in humans –potential for transmission of resistance elements from animals to humans –includes drugs used for treatment of disease which may be severe/ resistant to other therapies »fluoroquinolones for treatment of multi-drug resistant Salmonella infections

15 Factors in Ranking: Drug Efficacy u Drugs with unique mechanism of action –especially valuable to human medicine if no widespread resistance to drug in environment »linezolid for resistant Gram positive infections –limitation of use of drug beyond treatment of human disease may limit emergence of resistance –what is considered “unique” may change over time »more drugs marketed within a given class u norfloxacin compared to newer quinolones »emergence of resistance to members of a given class

16 Factors in Ranking: Drug Resistance u Cross resistance within drug class –importance of drugs within same class which have activity against organisms resistant to older members of class »organisms resistant to cefazolin may still be susceptible to ceftriaxone/cefotaxime –may vary with organism/drug class »Gram negative organisms resistant to gentamicin may be susceptible to amikacin »Gram positive organisms resistant to gentamicin usually resistant to amikacin

17 Factors in Ranking: Drug Resistance u Cross resistance across drug classes –plasmid-mediated resistance may transmit multiple resistance genes at once »plasmids in Gram negatives carrying resistance genes for beta-lactamases may also carry genes for sulfa drugs and chloramphenicol resistance –if linked cross resistance, drugs ranked according to class considered of highest importance –drugs which do not have “linked” resistance to other antimicrobials of particular importance »chromosomally mediated resistance to fluoroquinolones

18 Factors in Ranking: Drug Resistance u Ease of transmissibility of resistance –low = intrinsic resistance or change in target site that is not transmissible »chromosomal mutations and resistance to fluoroquinolones –high = single or multi-drug resistance that is transmissible »mobile resistance elements on plasmids and transposons such as plasmid mediated beta-lactamases –drugs with “low” transmissibility of resistance more likely ranked as more important in human medicine

19 Factors in Ranking: Drug Resistance u Cross-resistance between drugs used in animals and drugs used in humans –actual drug proposed for use in animals different from drug used in humans –resistance to animal drug can result in resistance to human drug »avoparcin use in animals could predict vancomycin resistance in humans –animal drug assigned importance of human drug

20 Factors in Ranking u Drugs of lesser importance –Little or no use in human medicine –Neither the first choice nor an important alternative for human infections »ionophores »polymyxins

21 Summary u Ranking of drugs according to human importance one part of overall framework document u Open for comments about ranking process u Evolving process based on changes in diseases, drugs and epidemiology of resistance